Inactive Instrument

Fresh Start Private Management Inc Share Price Other OTC

Equities

US35804J1025

Healthcare Facilities & Services

End-of-day quote Other OTC
- USD - Intraday chart for Fresh Start Private Management Inc
Sales 2022 2L 1.79Cr Sales 2023 89.16T 74.5L Capitalization 67.54L 56Cr
Net income 2022 -40L -33Cr Net income 2023 -30L -25Cr EV / Sales 2022 42.5 x
Net Debt 2022 16.09L 13Cr Net Debt 2023 17.47L 15Cr EV / Sales 2023 95.3 x
P/E ratio 2022
-1.61 x
P/E ratio 2023
-1.73 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 43.61%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 56 01/12/01
Chairman 55 13/13/13
President 75 01/19/01
Members of the board TitleAgeSince
President 75 01/19/01
Director/Board Member 64 01/19/01
Director/Board Member 56 01/19/01
More insiders
BioCorRx Inc., through its subsidiaries, develops and provides addiction treatment solutions for the treatment of substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. The Company, through its subsidiary, BioCorRx Pharmaceuticals Inc., is engaged in the development of BICX104, a subcutaneous implantable naltrexone pellet for the treatment of both opioid and alcohol use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.
More about the company